Navigation Links
Nation's Largest Healthcare Alliance Adds Roche HIV-1 Test to Existing Contract
Date:10/12/2007

Premier offers new Roche assay as its only real-time PCR test for HIV

INDIANAPOLIS, Oct. 12 /PRNewswire/ -- Premier Inc., the nation's largest healthcare alliance, gave its 1,700 hospital members access in August to the Roche COBAS(R) Ampliprep/COBAS(R) TaqMan(R) HIV-1 assay -- the only real-time PCR test for HIV offered to its members.

Premier added the new HIV-1 monitoring test, COBAS(R) TaqMan(R) 48 Analyzer and COBAS(R) TaqMan(R) Analyzer to its existing three-year molecular contract so that customers could combine the COBAS(R) Ampliprep, which was included in the existing molecular contract, with the COBAS(R) TaqMan(R) and the docking station to experience full automation.

"Adding the Roche HIV-1 monitoring test to Premier's menu is consistent with our mission to quickly roll out the highest level of innovation to our customers," said John Biggers, Group Vice President of Sourcing at Premier. "Premier also added COBAS(R) Taqman(R) 48 Analyzer, COBAS(R) Taqman(R) Analyzer and Roche's unique docking station so that customers could take advantage of the test's full automation while offering to their patients the most advanced HIV-1 monitoring assay based on 11 years of experience in HIV monitoring."

Roche introduced the fully automated COBAS(R) Ampliprep/COBAS(R) TaqMan(R) in response to customers' needs for a system that could allow their molecular laboratory technicians to load samples and walk away, not returning until the sample results are ready.

"Molecular technicians are in high demand," said Susan Zienowicz, Vice President for Molecular Diagnostics of Roche Diagnostics. "In creating the COBAS(R) Ampliprep/COBAS(R) TaqMan(R) HIV-1 assay, we provide labs with another strategy to help them leverage their employees' time and get more done in the lab."

About Premier Inc.

Serving 1,700 hospitals and more than 47,000 other healthcare sites, Premier is the largest healthcare alliance in the United States dedicated to improving patient outcomes while safely reducing the cost of care. Owned by not-for profit hospitals, Premier operates the nation's largest healthcare purchasing network, the most comprehensive repository of hospital clinical and financial information and one of the largest policy-holder owned, hospital professional liability risk-retention groups in healthcare. Headquartered in San Diego, Premier has offices in Charlotte, N.C. Philadelphia and Washington. For more information, visit http://www.premierinc.com.

About Roche and the Roche Diagnostics Division

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is a world leader in diagnostics, the leading supplier of drugs for cancer and transplantation and a market leader in virology. In 2006, sales by the Pharmaceuticals Division totaled 33.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.7 billion Swiss francs. Roche employs roughly 75,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai Roche's Diagnostics Division offers a uniquely broad product portfolio and supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories world-wide. For further information, please visit our Web site http://www.roche-diagnostics.us.

All trademarks used or mentioned in this release are legally protected by law.

For further information please contact:

Lori McLaughlin

Corporate Communications

317.521.3112

lori.mclaughlin@roche.com


'/>"/>
SOURCE Roche Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Roche offers HIV drug expertise to poor nations
2. Drug Combinations May Boost Stroke Risk
3. The Link Between Childhood Vaccinations And Diabetes Questioned
4. Research finds new explanations for dyslexia
5. Myth Of Childhood Vaccinations Linked To Increased Hospitalization Busted
6. Breast Cancer Examinations To Be Reviewed In Irish Hospitals
7. Asian Nations Told To Ready Themselves For Pandemic
8. Asian Nations To Take Joint Efforts Against H5N1
9. Media Plays Crucial Role In Flu Vaccinations
10. Drug Combinations Could Be Dangerous
11. Pediatricians Resignations Cause Concern at Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... 22, 2017 , ... In a recent article ... context (age, illness and life choices) should be dissociated from medical errors and ... In addition, all too often, studies regarding health system performance in other countries, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... for supply chain management (SCM) and spend management, today announced that Keppel Corporation ... time, and simplify expense tracking. , “We are excited to announce the ...
(Date:2/21/2017)... ... February 22, 2017 , ... Author Michèle Wolff has ... for every household and family to know all about it for optimal health. Wanting ... the release of “ Detox, Digestive and Wellness Solutions ” (published by Balboa Press ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... five new hospital-grade power extension cords that meet the most current standards. , ... 2012 edition of the National Fire Protection Association (NFPA) 101 – Life Safety ...
(Date:2/21/2017)... CA (PRWEB) , ... February 21, 2017 , ... Doctors ... , CA, directed by Dr. Kendell Mendonca , to its growing network of ... compensation injuries including injuries stemming from car accidents such as whiplash, back pain, neck ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 22, 2017  Bioness, Inc., the leading provider of ... first series of successful StimRouter Neuromodulation System implantations in ... Center (Nijmegen, Netherlands ), ... ), and Kliniek Park Leopold Chirec ( ... Bioness plans to further support clinicians across the continent ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 According ... (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & ... to 2021", published by MarketsandMarkets, the global market is poised to reach ... a CAGR of 13.3% from 2016 to 2021. ... ...
(Date:2/22/2017)... SEATTLE , Feb. 22, 2017 ... translational development of novel immune modulating therapies, today ... the a9a10 nicotinic acetylcholine receptor (nAChR), demonstrates robust ... preclinical pain models. The study also establishes the ... the treatment of chronic pain. The findings were ...
Breaking Medicine Technology: